Sale!

Immunohistochemistry LMO2 Test

510 د.إ

-11%

The Immunohistochemistry LMO2 test is a specialized diagnostic procedure used to detect the presence of the LMO2 protein in tissue samples. LMO2 is a protein that plays a critical role in the development of various types of blood cells and is associated with certain types of cancer, including some lymphomas and leukemias. This test is particularly important in the diagnostic and prognostic assessment of these diseases, helping healthcare providers to determine the best course of treatment for patients.

Performed in the sophisticated laboratory settings of DNA Labs UAE, this test involves the application of specific antibodies against the LMO2 protein on tissue sections, which are then visualized under a microscope. The presence, absence, or amount of LMO2 protein can provide valuable insights into the nature of the disease affecting the patient.

The cost of the Immunohistochemistry LMO2 test at DNA Labs UAE is 510 AED. This price reflects the comprehensive nature of the test, from the procurement of specific antibodies to the expertise required for accurate interpretation of the results. Patients and healthcare providers considering this test can expect state-of-the-art facilities and highly trained professionals at DNA Labs UAE, ensuring reliable and timely diagnostic information.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY LMO2 Test

Test Name: IMMUNOHISTOCHEMISTRY LMO2 Test

Components:

  • Price: 510.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery:

  • Sample: Daily by 6 pm
  • Report Block: 5 days
  • Tissue Biopsy: 5 days
  • Tissue large complex: 7 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist

Test Department: HISTOLOGY

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details:

The LMO2 test is an immunohistochemistry (IHC) test used to detect the presence of LMO2 protein in tissue samples. LMO2 is a transcription factor that plays a critical role in hematopoiesis (the formation of blood cells) and is also involved in the development of certain types of leukemia and lymphoma.

The LMO2 IHC test involves staining tissue sections with specific antibodies that can bind to the LMO2 protein. These antibodies are usually labeled with a chromogen or a fluorescent dye, which allows visualization of the LMO2 protein under a microscope. The staining pattern and intensity can provide information about the expression level and localization of LMO2 in the tissue.

The LMO2 test is commonly used in research and clinical settings to study the role of LMO2 in normal and diseased tissues. It can help in the diagnosis and classification of hematopoietic malignancies, as well as in the identification of potential therapeutic targets. Additionally, the LMO2 test can be used to monitor the response to treatment and to assess the prognosis of patients with LMO2-associated cancers.

Overall, the LMO2 immunohistochemistry test is a valuable tool in the field of oncology and hematopathology, providing important information about the expression and localization of LMO2 protein in tissue samples.

Test Name IMMUNOHISTOCHEMISTRY LMO2 Test
Components
Price 510.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The LMO2 test is an immunohistochemistry (IHC) test used to detect the presence of LMO2 protein in tissue samples. LMO2 is a transcription factor that plays a critical role in hematopoiesis (the formation of blood cells) and is also involved in the development of certain types of leukemia and lymphoma.

The LMO2 IHC test involves staining tissue sections with specific antibodies that can bind to the LMO2 protein. These antibodies are usually labeled with a chromogen or a fluorescent dye, which allows visualization of the LMO2 protein under a microscope. The staining pattern and intensity can provide information about the expression level and localization of LMO2 in the tissue.

The LMO2 test is commonly used in research and clinical settings to study the role of LMO2 in normal and diseased tissues. It can help in the diagnosis and classification of hematopoietic malignancies, as well as in the identification of potential therapeutic targets. Additionally, the LMO2 test can be used to monitor the response to treatment and to assess the prognosis of patients with LMO2-associated cancers.

Overall, the LMO2 immunohistochemistry test is a valuable tool in the field of oncology and hematopathology, providing important information about the expression and localization of LMO2 protein in tissue samples.